Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

psychiatric diseases

- PMLiVE

German doctors criticise EU clinical trial reform plans

Could compromise patient safety says German Medical Association

Board member Engelbert Tjeenk Willink to leave Boehringer

Replaced by head of established markets Allan Hillgrove

- PMLiVE

Board member Engelbert Tjeenk Willink to leave Boehringer

Replaced by head of established markets Allan Hillgrove

Ten pharma firms team up on new drug development

Joint venture to take on some of the key challenges and bottlenecks in drug development

- PMLiVE

Boehringer cancer R&D programme bears first fruit

Submits afatinib in Europe to treat lung cancer

- PMLiVE

Sanofi taps Oncodesign for kinase inhibitor platform

French firms form €130m alliance

Pfizer forms branded generics sales alliance in China

Forms joint venture with local company Hisun

- PMLiVE

AstraZeneca forges CRO alliance to bring biologic to China

MedImmune Subsidiary forms joint venture with WuXi

- PMLiVE

WebMD expands European operations with Medscape Germany

Local version of the doctors' portal follows launch of Medscape France

- PMLiVE

Merck KGaA plans to cut 1,100 jobs in Germany

Production also halted at two German facilities

Lilly drops touted Zyprexa successor for use in schizophrenia

Pomaglumetad methionil disappoints in phase III

WorldOne signs real-time patient perception partnership

Health data company will collaborate with patient intelligence platform Treato

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links